LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/ulrich medical Introduces New Spine Implant
Spine

ulrich medical Introduces New Spine Implant

December 3, 2012 1 min read Premium comments

Advertisement

ulrich medical Introduces New Spine Implant
Courtesy of Ulrich Medical
Secondary

ulrich medical USA is releasing to the U.S. market its Occipito-Cervico-Thoracic (OCT) System, a low profile, German-engineered spinal implant system designed for the surgical stabilization and fixation of the posterior regions of the spine.

Company officials describe the neon OCT System as including hybrid occipital plate/rods and straight rods, self-drilling and self-tapping screws, cannulated screws, screw-to-rod connectors, spacers, hooks and rod-to-rod crosslinks. The system also utilizes a 4.5mm titanium alloy rod over market-standard 3.0/3.5mm rods. The neon posted screw design allows for what company officials claim to be optimal screw placement and ease of rod attachment at varying angles, heights and directions to better accommodate patient anatomy and pathology.

“We are very excited to bring the robust and versatile neon OCT Spine System to the U.S. market. This is the only complex spine system in its product class with a 4.5mm rod, which provides for very rigid and strong construct options with optimum adaptability to the anatomy, especially in complex trauma and tumor applications, ” said Erika Laskey, vice president of sales and marketing, ulrich medical USA.

ulrich medical USA, Inc. is a privately held subsidiary of ulrich medical, a medical technology company headquartered in Ulm, Germany. The company is celebrating its 100th year in business.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy